Xanthines and their therapeutic use
US5821366A · kind A · utility
1Cited by
1References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 20, 1996 |
| Grant date | Oct 13, 1998 |
| Priority date | — |
| Expiry date | May 20, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
1,3-Disubstituted-zanthines have therapeutic utility via TNF or phosphodiesterase inhibition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.